Checking heart risk with a blood test in lupus kidney disease
Part of Immune system & allergy, Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.
This study tests a simple, needle-free method to check for early heart and blood vessel disease in people with lupus nephritis (kidney inflammation from lupus). It uses a formula based on your blood sugar and fat levels to see if you are at higher risk, without needing special scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have been diagnosed with systemic lupus (SLE) and lupus nephritis (kidney inflammation from lupus).
- You must not have any known heart or blood vessel disease (like a heart attack or stroke).
- You must not have diabetes, obesity, high cholesterol, or high blood pressure.
- You must not have other major health issues like chronic kidney disease, infections, other autoimmune diseases, pregnancy, cancer, or liver disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a simple urine test to see if it can show how active lupus nephritis (kidney inflammation caused by lupus) is. It might help doctors monitor the condition without needing repeated biopsies.
This study looks at two simple blood tests to predict whether people with lupus nephritis (a kidney disease caused by lupus) may need intensive care or have a higher risk of dying in the hospital. It aims to help doctors identify who needs closer monitoring.
This study looks at whether certain blood test ratios (albumin/globulin and platelet/albumin) can help identify or predict lupus nephritis, a kidney problem caused by lupus. It may help doctors better understand and manage kidney involvement in lupus patients.
This study looks at a simple blood test (called the Systemic Immune Inflammatory Index) to see if it can help doctors understand how active lupus is in your body. It includes people with lupus, especially those with kidney involvement, to find better ways to track the disease.
This trial uses an ultrasound to measure kidney blood flow in people with lupus kidney disease. The goal is to see if this simple test can tell how active the disease is, which might help doctors adjust treatment without needing frequent biopsies.
This study looks at whether certain substances in the blood, such as uric acid, homocysteine, and interleukin-17, are higher in people with lupus-related kidney disease compared to healthy individuals. It aims to find new ways to monitor or understand the condition better.
Hear when a new Systemic Lupus Erthematosus (SLE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.